shares authorized;
16,673 shares issued and
outstanding at September 30,
2008; 12,055 shares issued
and outstanding at
December 31, 2007 5,502 3,978
Additional paid-in capital 35,408 34,320
Accumulated deficit (40,369) (36,567)
Total stockholders' (deficit)
equity 552 1,743
Total liabilities and
stockholders' equity $8,808 $8,174
PATIENT SAFETY TECHNOLOGIES, INC. AND SUBSIDIARY
Condensed Consolidated Statements of Operations (Unaudited)
(In thousands, except per share data)
For The Three Months Ended For The Nine Months Ended
September 30, September 30,
2008 2007 2008 2007
Revenues $880 $213 $1,937 $834
Cost of revenue 622 112 1,342 514
Gross profit 258 101 595 320
Operating expenses:
Research and
development 87 39 168 91
Sales and marketing 662 418 1,796 1,090
General and
administrative 958 764 3,680 2,790
Total operating
expenses 1,707 1,221 5,644 3,971
Operating loss (1,449) (1,120) (5,049) (3,651)
Other income (expenses):
Interest expense (79) (810) (254) (1,414)
Change in fair value
of warrant liability 1,683 - 1,515 -
Realized
'/>"/>SOURCE Patient Safety Technologies Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 Related medicine news :1.
The First Treatment Specifically Approved for Huntingtons Disease Patients is Now Available in the United States2.
Life-Saving Airman, Leukemia Patient Meet for First Time3.
New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes4.
Final Rule Issued for Patient Safety Organizations5.
Heart patients are often not treated in accordance with guidelines6.
New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 7.
Initial Survey Findings on Diabetes Awareness Released by PatientAssistance.com8.
When the Caregiver Becomes the Patient9.
Caution Urged as Patients Seek Deals on Cosmetic Surgery10.
Kaiser Permanente Receives the Most Stars in California Office of Patient Advocates Annual Quality Report Card11.
New Jersey Jury Awards $12.9 Million to Three Patients Whose Use of Roche Acne Medication Accutane Found to Cause Severe Bowel Illness